The opioid epidemic has resulted in significant increases in Hepatitis C Virus (HCV) among people who inject drugs, accounting for 23% of new infections. HCV is completely curable and testing and treatment are the path to cure. Opioid Treatment Providers (OTPs) play a critical role in comprehensive approaches to addressing HCV and this guide is one tool to help.
AATOD has been collaborating with the ATTC Network Coordinating Office and other leading organizations to develop a guide that will provide OTPs with concrete steps for OUD and HCV testing and treatment integration.
GREAT NEWS!! The guide “Your Guide for Implementing HCV Services in Opioid Treatment Programs” has launched and is available.
Your Guide to Integrating HCV Services into Opioid Treatment Programs can help build the capacity of publicly funded OTPs to integrate HCV prevention and treatment services into their programs. This guide may also be useful for Federally Qualified Health Centers (FQHCs), community and healthcare coalitions, nonprofit organizations and other substance use disorder and HCV treatment providers.
It should be noted that AATOD was advised that there is a plan to identify ways to support OTPs that wish to use the guide to aid in service integration.
